ATE297941T1 - Verfahren zur herstellung von einer kristallinen form ii von clarythromycin - Google Patents
Verfahren zur herstellung von einer kristallinen form ii von clarythromycinInfo
- Publication number
- ATE297941T1 ATE297941T1 AT01106198T AT01106198T ATE297941T1 AT E297941 T1 ATE297941 T1 AT E297941T1 AT 01106198 T AT01106198 T AT 01106198T AT 01106198 T AT01106198 T AT 01106198T AT E297941 T1 ATE297941 T1 AT E297941T1
- Authority
- AT
- Austria
- Prior art keywords
- clarithromycin
- water
- trimethylsilyl
- oxime
- group
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 229960002626 clarithromycin Drugs 0.000 abstract 6
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 abstract 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 2
- LKGCPYOBWLSCTK-UHFFFAOYSA-N methanesulfonic acid;trihydrate Chemical compound O.O.O.CS(O)(=O)=O LKGCPYOBWLSCTK-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- KYTWXIARANQMCA-RWJQBGPGSA-N (3r,4s,5s,6r,7r,9r,11s,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-10-hydroxyimino-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2 Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=NO)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 KYTWXIARANQMCA-RWJQBGPGSA-N 0.000 abstract 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 abstract 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 1
- 229930006677 Erythromycin A Natural products 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 229960003276 erythromycin Drugs 0.000 abstract 1
- 229940098779 methanesulfonic acid Drugs 0.000 abstract 1
- 239000012022 methylating agents Substances 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 125000003544 oxime group Chemical group 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020000013033A KR100361397B1 (ko) | 2000-03-15 | 2000-03-15 | 에리스로마이신 에이 9-오-트로필옥심 유도체를 이용한클라리스로마이신의 제조방법 |
| KR10-2000-0069834A KR100367981B1 (ko) | 2000-11-23 | 2000-11-23 | 클라리스로마이신 결정형 2의 제조 방법 및 이 방법에사용되는 결정성 클라리스로마이신 메실레이트 삼수화물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE297941T1 true ATE297941T1 (de) | 2005-07-15 |
Family
ID=36274127
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01106198T ATE297941T1 (de) | 2000-03-15 | 2001-03-14 | Verfahren zur herstellung von einer kristallinen form ii von clarythromycin |
| AT04013295T ATE338053T1 (de) | 2000-03-15 | 2001-03-14 | Verfahren zur herstellung von clarythromycin mit nicht pharmazeutischer qualität |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04013295T ATE338053T1 (de) | 2000-03-15 | 2001-03-14 | Verfahren zur herstellung von clarythromycin mit nicht pharmazeutischer qualität |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6515116B2 (de) |
| EP (2) | EP1134229B1 (de) |
| JP (1) | JP4119125B2 (de) |
| CN (1) | CN1193036C (de) |
| AT (2) | ATE297941T1 (de) |
| AU (1) | AU771825B2 (de) |
| BR (1) | BR0109194A (de) |
| CA (1) | CA2402201C (de) |
| DE (2) | DE60122791T2 (de) |
| ES (2) | ES2242668T3 (de) |
| HU (1) | HUP0300418A3 (de) |
| MX (1) | MXPA02008861A (de) |
| NZ (1) | NZ521184A (de) |
| RU (1) | RU2230748C2 (de) |
| WO (1) | WO2001068662A1 (de) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
| AU2578701A (en) * | 2000-02-29 | 2001-09-12 | Teva Pharma | Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same |
| KR100367981B1 (ko) * | 2000-11-23 | 2003-01-14 | 한미약품공업 주식회사 | 클라리스로마이신 결정형 2의 제조 방법 및 이 방법에사용되는 결정성 클라리스로마이신 메실레이트 삼수화물 |
| KR20030011797A (ko) * | 2000-03-28 | 2003-02-11 | 바이오케미 게젤샤프트 엠베하 | 맛이 차폐된 과립형 입자 |
| US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
| US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
| US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
| US20060083759A1 (en) * | 2002-07-17 | 2006-04-20 | Aleksander Resman | Stabilization of the profile of release of active substances from a formulation |
| EP1638549A4 (de) | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | Neue antibakterielle mittel |
| ES2221807B1 (es) * | 2003-06-24 | 2005-12-16 | Ercros Industrial, S.A. | Un procedimiento para la obtencion de claritromicina. |
| CA2533292C (en) * | 2003-07-21 | 2013-12-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
| EP1648415A4 (de) * | 2003-07-21 | 2011-11-16 | Middlebrook Pharmaceuticals Inc | Antibiotisches produkt, seine verwendung und formulierung |
| EP1648418A4 (de) * | 2003-07-21 | 2011-11-16 | Middlebrook Pharmaceuticals Inc | Antibiotisches produkt, seine verwendung und formulierung |
| WO2005016311A1 (en) * | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
| CA2535398C (en) * | 2003-08-12 | 2013-11-12 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
| EP1658034A4 (de) * | 2003-08-29 | 2011-06-22 | Middlebrook Pharmaceuticals Inc | Antibiotisches produkt, seine verwendung und formulierung |
| WO2005027877A1 (en) * | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
| US8715727B2 (en) * | 2004-07-02 | 2014-05-06 | Shionogi Inc. | Tablet for pulsed delivery |
| CN101073284B (zh) * | 2005-02-07 | 2010-05-05 | 中兴通讯股份有限公司 | 一种控制系统间测量和频间测量的方法 |
| WO2007015265A2 (en) * | 2005-05-24 | 2007-02-08 | Kopran Research Laboratories Ltd | A process for preparing 6,9-imino ether |
| JP2009500356A (ja) * | 2005-07-07 | 2009-01-08 | エラン ファーマ インターナショナル リミテッド | ナノ粒子クラリスロマイシン製剤 |
| WO2007036951A2 (en) * | 2005-08-31 | 2007-04-05 | Alembic Limited | Process to obtain 6-o-methylerythromycin a (clarithromycin)_form ii |
| US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
| US8778924B2 (en) * | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
| US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
| EP2030613A1 (de) | 2007-08-17 | 2009-03-04 | Abbott GmbH & Co. KG | Herstellung von Zusammensetzungen mit hauptsächlich nichtkristallinen eingebetteten Makrolid-Antibiotika |
| CA2703475A1 (en) * | 2007-10-25 | 2009-04-30 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| US8796232B2 (en) * | 2008-10-24 | 2014-08-05 | Cempra Pharmaceuticals, Inc. | Methods for treating resistant diseases using triazole containing macrolides |
| CN101787063B (zh) * | 2009-01-23 | 2012-12-19 | 刘力 | 抗感染药物及其制备和用途 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| JP5914335B2 (ja) | 2009-09-10 | 2016-05-11 | センプラ ファーマシューティカルズ，インコーポレイテッド | マラリア、結核、及びｍａｃ病の治療方法 |
| CN103080122A (zh) | 2010-03-22 | 2013-05-01 | 森普拉制药公司 | 大环内脂的结晶形式及其用途 |
| WO2011146829A1 (en) * | 2010-05-20 | 2011-11-24 | Cempra Pharmaceuticals, Inc. | Processes for preparing macrolides and ketolides and intermediates therefor |
| JP6042334B2 (ja) | 2010-09-10 | 2016-12-14 | センプラ ファーマシューティカルズ，インコーポレイテッド | 疾患治療のための水素結合形成フルオロケトライド |
| CN104470527B (zh) | 2012-03-27 | 2019-05-28 | 森普拉制药公司 | 用于施用大环内酯抗生素的肠胃外制剂 |
| CN103897002A (zh) * | 2012-12-31 | 2014-07-02 | 菏泽市方明制药有限公司 | 一种粗品硫氰酸红霉素制备红霉素a9-肟的方法 |
| CN103087130B (zh) * | 2013-02-06 | 2015-12-23 | 浙江国邦药业有限公司 | 一种克拉霉素晶型转换方法 |
| RU2015138796A (ru) | 2013-03-14 | 2017-04-19 | Семпра Фармасьютикалс, Инк. | Способы и составы для лечения респираторных заболеваний |
| WO2014145210A1 (en) | 2013-03-15 | 2014-09-18 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60214796A (ja) * | 1984-04-06 | 1985-10-28 | Taisho Pharmaceut Co Ltd | ６−０−メチルエリスロマイシン類の製法 |
| US4670549A (en) * | 1985-03-18 | 1987-06-02 | Taisho Pharmaceutical Co., Ltd. | Method for selective methylation of erythromycin a derivatives |
| DE3782994T2 (de) * | 1986-09-18 | 1993-04-08 | Taisho Pharma Co Ltd | Erythromycin-a-derivate und verfahren zu ihrer herstellung. |
| KR960000434B1 (ko) * | 1986-12-17 | 1996-01-06 | 다이쇼 세이야꾸 가부시끼가이샤 | 에리스로마이신 a유도체 및 그의 제조 방법 |
| SI9011409A (en) * | 1990-07-18 | 1995-10-31 | Pliva Pharm & Chem Works | O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them |
| US5872229A (en) * | 1995-11-21 | 1999-02-16 | Abbott Laboratories | Process for 6-O-alkylation of erythromycin derivatives |
| US5837829A (en) * | 1996-04-02 | 1998-11-17 | Abbott Laboratories | 9-oximesilyl erythromycin a derivatives |
| US5858986A (en) * | 1996-07-29 | 1999-01-12 | Abbott Laboratories | Crystal form I of clarithromycin |
| PT915899E (pt) * | 1996-07-29 | 2004-11-30 | Abbott Lab | Preparacao da forma cristalina ii da eritromicina |
| US5945405A (en) * | 1997-01-17 | 1999-08-31 | Abbott Laboratories | Crystal form O of clarithromycin |
| US5864023A (en) * | 1997-02-13 | 1999-01-26 | Abbott Laboratories | 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives |
| IL135792A0 (en) * | 1997-12-01 | 2001-05-20 | Abbott Lab | 6-o-alkyl derivatives of erythronolide b |
| US6258785B1 (en) * | 1998-12-02 | 2001-07-10 | Pfizer Inc. | Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin |
-
2001
- 2001-03-14 CN CNB018096050A patent/CN1193036C/zh not_active Expired - Fee Related
- 2001-03-14 AT AT01106198T patent/ATE297941T1/de not_active IP Right Cessation
- 2001-03-14 EP EP01106198A patent/EP1134229B1/de not_active Expired - Lifetime
- 2001-03-14 AU AU42827/01A patent/AU771825B2/en not_active Ceased
- 2001-03-14 AT AT04013295T patent/ATE338053T1/de not_active IP Right Cessation
- 2001-03-14 MX MXPA02008861A patent/MXPA02008861A/es active IP Right Grant
- 2001-03-14 BR BR0109194-8A patent/BR0109194A/pt not_active IP Right Cessation
- 2001-03-14 CA CA002402201A patent/CA2402201C/en not_active Expired - Fee Related
- 2001-03-14 WO PCT/KR2001/000394 patent/WO2001068662A1/en not_active Ceased
- 2001-03-14 US US09/805,831 patent/US6515116B2/en not_active Expired - Fee Related
- 2001-03-14 ES ES01106198T patent/ES2242668T3/es not_active Expired - Lifetime
- 2001-03-14 EP EP04013295A patent/EP1469008B1/de not_active Expired - Lifetime
- 2001-03-14 ES ES04013295T patent/ES2270226T3/es not_active Expired - Lifetime
- 2001-03-14 DE DE60122791T patent/DE60122791T2/de not_active Expired - Lifetime
- 2001-03-14 DE DE60111438T patent/DE60111438T2/de not_active Expired - Lifetime
- 2001-03-14 JP JP2001567752A patent/JP4119125B2/ja not_active Expired - Fee Related
- 2001-03-14 NZ NZ521184A patent/NZ521184A/en unknown
- 2001-03-14 HU HU0300418A patent/HUP0300418A3/hu unknown
- 2001-03-14 RU RU2002127591/04A patent/RU2230748C2/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2002127591A (ru) | 2004-02-27 |
| RU2230748C2 (ru) | 2004-06-20 |
| JP2004500398A (ja) | 2004-01-08 |
| HUP0300418A3 (en) | 2003-09-29 |
| CN1193036C (zh) | 2005-03-16 |
| ATE338053T1 (de) | 2006-09-15 |
| US20010039333A1 (en) | 2001-11-08 |
| HUP0300418A2 (hu) | 2003-06-28 |
| US6515116B2 (en) | 2003-02-04 |
| JP4119125B2 (ja) | 2008-07-16 |
| EP1134229B1 (de) | 2005-06-15 |
| AU4282701A (en) | 2001-09-24 |
| CA2402201A1 (en) | 2001-09-20 |
| NZ521184A (en) | 2004-02-27 |
| BR0109194A (pt) | 2003-02-11 |
| DE60122791T2 (de) | 2007-10-04 |
| ES2242668T3 (es) | 2005-11-16 |
| CN1429233A (zh) | 2003-07-09 |
| WO2001068662A1 (en) | 2001-09-20 |
| DE60111438D1 (de) | 2005-07-21 |
| DE60111438T2 (de) | 2006-05-18 |
| ES2270226T3 (es) | 2007-04-01 |
| EP1134229A2 (de) | 2001-09-19 |
| EP1134229A3 (de) | 2002-02-27 |
| MXPA02008861A (es) | 2003-02-10 |
| CA2402201C (en) | 2007-06-05 |
| EP1469008B1 (de) | 2006-08-30 |
| EP1469008A1 (de) | 2004-10-20 |
| DE60122791D1 (de) | 2006-10-12 |
| AU771825B2 (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60111438D1 (de) | Verfahren zur Herstellung von einer kristallinen Form II von Clarythromycin | |
| ATE232211T1 (de) | Verfahren zur herstellung von form ii kristallen des clarithromycins | |
| EP1070077B1 (de) | 15-gliedrige ketolid-lactame mit antibakterieller wirkung | |
| DE29724846U1 (de) | Herstellung von kristalliner Form II von Clarithromycin | |
| KR20030047873A (ko) | 클라리트로마이신 및 클라리트로마이신 중간체의 제조방법, 실질적으로는 옥심이 제거된 클라리트로마이신 및이를 포함하는 약학적 조성물 | |
| DE60031154D1 (de) | Verfahren zur herstellung von clarithromycin | |
| DE69824201T2 (de) | Neue 9a-azalide | |
| ATE309262T1 (de) | Verfahren zur herstellung von aufgereinigtem anthocyanin und kristallines anthocyanin | |
| CA1178596A (en) | 4"-epi erythromycin a and derivatives thereof as useful antibacterial agents | |
| DE60029439T2 (de) | Neue 8a- und 9a-lactame mit 15 ringatomen | |
| WO2002018403A1 (fr) | Procede permettant la production d'un derive d'erythromycine | |
| DE69613971T2 (de) | Oligonukelotide mit transversalkovalenter bindung, verfahren zu ihrer herstellung und darin benutztes synthon | |
| EP0262905A2 (de) | Modifizierungen in 3-0-Demethyl-Mycinose in Macrocin und Lactenocin | |
| ES2195727A1 (es) | Un procedimiento para la obtencion de claritromicina. | |
| HUP0201693A2 (en) | Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative, process for producing it and its pharmaceutical composition | |
| DE69935250T2 (de) | Oleandomycin-derivate | |
| DE69704778D1 (de) | Verfahren zur herstellung von salzen von erythromicyn, roxithromicyn, clarythromicyn und azithromycin | |
| ATE238331T1 (de) | Neue hydroxyderivate von tylosin und verfahren zu deren herstellung | |
| KR890000510A (ko) | 3'- 아지도-3'- 데옥시미딘의 신규화학적 제조방법 | |
| ATE303395T1 (de) | Verfahren zur herstellung einer erythromycinverbindung | |
| MXPA00009875A (es) | Cetolidos de lactamas de 15 miembros con actividad antibacteriana | |
| EP1444244A1 (de) | Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte | |
| MXPA00004863A (en) | Process for n-desmethylating erythromycins and derivatives thereof | |
| DE3308563A1 (de) | 3-epistreptomycin und sein dihydroderivat, verfahren zu deren herstellung und diese enthaltende zusammensetzung | |
| ATE187432T1 (de) | Natrium-orthohydroxymandelat-phenol-wasser- komplexe, verfahren zu deren herstellung sowie verwendung zur isolation des natrium orthohydroxymandelats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |